CNS PHARMACEUTICALS, INC. (CNSP): $2.11

0.11 (+5.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CNS Pharmaceuticals Inc (CNSP) Price Targets From Analysts

Use the tables below to see what analysts covering CNS Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $10 $7 $8.33 $2.04 308.33%

The Trend in the Analyst Price Target


Over the past 15 months, CNSP's average price target has gone down $2.67.

Over the past 15 months, CNSP's average upside potential has been 290.68%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 3 10 7 8.33 2.01 314.43%
2021-06-05 3 10 7 8.33 2.05 306.34%
2021-05-22 3 10 7 8.33 1.87 345.45%
2021-05-15 3 10 7 8.33 1.79 365.36%
2021-05-08 3 10 7 8.33 1.84 352.72%
2021-04-25 3 10 7 8.33 2.05 306.34%
2021-04-17 3 10 7 8.33 2.08 300.48%
2021-04-10 3 10 7 8.33 2.23 273.54%
2021-04-03 3 10 7 8.33 2.36 252.97%
2021-03-20 3 10 7 8.33 2.70 208.52%
2021-03-13 3 10 7 8.33 2.67 211.99%
2021-03-06 3 10 7 8.33 2.35 254.47%
2021-02-27 3 10 7 8.33 2.63 216.73%
2021-02-20 3 10 7 8.33 3.08 170.45%
2021-02-13 3 10 7 8.33 3.44 142.15%
2021-02-06 3 10 7 8.33 3.36 147.92%
2021-01-30 2 8 7 7.50 1.72 336.05%
2021-01-23 2 8 7 7.50 2.04 267.65%
2021-01-16 2 8 7 7.50 1.92 290.62%
2021-01-09 2 8 7 7.50 1.81 314.36%
2021-01-02 2 8 7 7.50 1.78 321.35%
2020-12-26 3 11 7 8.67 1.78 387.08%
2020-12-19 3 11 7 8.67 2.89 200%
2020-12-10 2 11 8 9.50 2.54 274.02%
2020-12-07 2 11 8 9.50 2.36 302.54%
2020-11-28 2 11 8 9.50 2.40 295.83%
2020-11-03 2 11 8 9.50 1.70 458.82%
2020-08-21 2 11 8 9.50 1.73 449.13%
2020-08-20 1 8 8 8.00 1.73 362.43%
2020-03-13 1 11 11 11.00 NA NA%

CNSP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 0 3 0 0 0 3

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The upside potential (average analyst target price relative to current price) of CNSP is higher than 95.8% of all US stocks.
  • CNS Pharmaceuticals Inc's average analyst price target is higher than 16.21% of all US stocks.
  • CNS Pharmaceuticals Inc's variance in analysts' estimates is less than 20% of stocks in the micro market cap category.
  • CNSP has a higher number of analysts covering the stock than 22.88% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CNS Pharmaceuticals Inc are PRPH, ASRT and INM.

Make investment decisions regarding CNSP using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7361 seconds.